Xometry (NASDAQ:XMTR) Director Sells $908,200.00 in Stock

Key Points

• Xometry Director Randolph Altschuler sold 10,000 shares at an average price of $90.82, generating $908,200 and reducing his ownership by 1.78% to 551,270 shares.
• Xometry shares traded at $93.04, with the stock up strongly from its 52-week low of $35.86 but below its $106.08 high. The company recently beat quarterly earnings and revenue estimates, with revenue rising 41.1% year over year.
• Analysts maintain a generally positive outlook, with a consensus “Moderate Buy” rating and an average price target of $108.33, while institutional investors own 97.31% of the company.

Xometry, Inc. (NASDAQ:XMTR - Get Free Report) Director Randolph Altschuler sold 10,000 shares of Xometry stock in a transaction that occurred on Tuesday, September 1st. The stock was sold at an average price of $90.82, for a total transaction of $908,200.00. Following the completion of the sale, the director owned 551,270 shares of the company's stock, valued at $50,066,341.40. This represents a 1.78% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.

Randolph Altschuler also recently made the following trade(s):

• On Thursday, July 2nd, Randolph Altschuler sold 5,722 shares of Xometry stock. The shares were sold at an average price of $93.30, for a total transaction of $533,862.60.

Xometry Stock Performance

NASDAQ:XMTR traded up $0.81 during trading hours on Thursday, reaching $93.04. The company had a trading volume of 428,976 shares, compared to its average volume of 891,916. The company has a current ratio of 3.21, a quick ratio of 3.20 and a debt-to-equity ratio of 0.41. Xometry, Inc. has a 52 week low of $35.86 and a 52 week high of $106.08. The firm has a market cap of $4.82 billion, a price-to-earnings ratio of -155.06 and a beta of 1.32. The firm's 50 day moving average price is $91.58 and its 200-day moving average price is $71.92.

Xometry (NASDAQ:XMTR - Get Free Report) last released its quarterly earnings results on Tuesday, August 4th. The company reported $0.16 earnings per share for the quarter, beating the consensus estimate of $0.15 by $0.01. The firm had revenue of $229.28 million for the quarter, compared to analysts' expectations of $215.22 million. Xometry had a negative return on equity of 2.88% and a negative net margin of 3.82%.The company's revenue was up 41.1% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.09 EPS. On average, analysts forecast that Xometry, Inc. will post -0.01 EPS for the current year.

Institutional Trading of Xometry

Hedge funds have recently bought and sold shares of the stock. California State Teachers Retirement System raised its stake in shares of Xometry by 9,368.5% in the second quarter. California State Teachers Retirement System now owns 4,901,865 shares of the company's stock worth $473,128,000 after buying an additional 4,850,095 shares during the period. Fuller & Thaler Asset Management Inc. bought a new position in shares of Xometry during the 4th quarter valued at approximately $76,393,000. Ameriprise Financial Inc. grew its stake in shares of Xometry by 54.2% during the 3rd quarter. Ameriprise Financial Inc. now owns 1,964,909 shares of the company's stock valued at $107,029,000 after acquiring an additional 690,558 shares during the period. Durable Capital Partners LP purchased a new stake in Xometry in the 3rd quarter worth approximately $36,455,000. Finally, Allspring Global Investments Holdings LLC raised its stake in Xometry by 243.6% during the 1st quarter. Allspring Global Investments Holdings LLC now owns 694,390 shares of the company's stock worth $29,015,000 after acquiring an additional 492,285 shares during the period. Institutional investors own 97.31% of the company's stock.

Wall Street Analysts Forecast Growth

A number of research firms have issued reports on XMTR. The Goldman Sachs Group boosted their price target on Xometry from $78.00 to $104.00 and gave the company a "neutral" rating in a research note on Wednesday, August 5th. Weiss Ratings reiterated a "sell (d-)" rating on shares of Xometry in a research note on Wednesday, August 26th. Rosenblatt Securities initiated coverage on shares of Xometry in a report on Thursday, August 20th. They issued a "buy" rating and a $110.00 price objective on the stock. Cantor Fitzgerald boosted their target price on shares of Xometry from $85.00 to $110.00 and gave the company an "overweight" rating in a research report on Wednesday, August 5th. Finally, UBS Group upped their target price on shares of Xometry from $88.00 to $95.00 and gave the company a "neutral" rating in a report on Wednesday, August 5th. One analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating, four have issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $108.33.

Xometry Company Profile

Xometry, Inc NASDAQ: XMTR operates a technology-driven marketplace that connects businesses with on-demand manufacturing capacity across a wide array of processes. Through its proprietary Instant Quoting Engine and Xometry Platform, the company streamlines sourcing for CNC machining, 3D printing, sheet metal fabrication, injection molding, urethane casting and other custom manufacturing services. By aggregating a network of thousands of vetted suppliers, Xometry offers rapid lead times, transparent pricing and real-time order tracking to customers in sectors ranging from automotive and aerospace to medical devices and industrial equipment.

Since its founding in 2013 and headquarters in Rockville, Maryland, Xometry has expanded its geographic reach to serve customers in North America, Europe and beyond.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source